Jennifer F. De Los Santos, Alan Cantor, Keith D. Amos, Andres Forero, Mehra Golshan, Janet K. Horton, Clifford A. Hudis, Nola M. Hylton, Kandace McGuire, Funda Meric-Bernstam, Ingrid M. Meszoely, Rita Nanda and E. Shelley Hwang Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer Cancer 119
Version of Record online: 21 FEB 2013 | DOI: 10.1002/cncr.27995
In this study, the overall accuracy of magnetic resonance imaging for predicting a pathologic complete response in 746 patients with invasive breast cancer receiving neoadjuvant chemotherapy is 74%. Magnetic resonance performance differs among subtypes, possibly influenced by absolute differences in pathologic complete response rates.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field